Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells

Front Oncol. 2024 Dec 6;14:1532291. doi: 10.3389/fonc.2024.1532291. eCollection 2024.

ABSTRACT

[This corrects the article DOI: 10.3389/fonc.2022.942341.].

PMID:39711960 | PMC:PMC11660793 | DOI:10.3389/fonc.2024.1532291